17
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Metabolic etiologies in West syndrome

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Summary

          West syndrome ( WS) is an early life epileptic encephalopathy associated with infantile spasms, interictal electroencephalography ( EEG) abnormalities including high amplitude, disorganized background with multifocal epileptic spikes (hypsarrhythmia), and often neurodevelopmental impairments. Approximately 64% of the patients have structural, metabolic, genetic, or infectious etiologies and, in the rest, the etiology is unknown. Here we review the contribution of etiologies due to various metabolic disorders in the pathology of WS. These may include metabolic errors in organic molecules involved in amino acid and glucose metabolism, fatty acid oxidation, metal metabolism, pyridoxine deficiency or dependency, or acidurias in organelles such as mitochondria and lysosomes. We discuss the biochemical, clinical, and EEG features of these disorders as well as the evidence of how they may be implicated in the pathogenesis and treatment of WS. The early recognition of these etiologies in some cases may permit early interventions that may improve the course of the disease.

          Related collections

          Most cited references316

          • Record: found
          • Abstract: found
          • Article: not found

          Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes.

          Patients with permanent neonatal diabetes usually present within the first three months of life and require insulin treatment. In most, the cause is unknown. Because ATP-sensitive potassium (K(ATP)) channels mediate glucose-stimulated insulin secretion from the pancreatic beta cells, we hypothesized that activating mutations in the gene encoding the Kir6.2 subunit of this channel (KCNJ11) cause neonatal diabetes. We sequenced the KCNJ11 gene in 29 patients with permanent neonatal diabetes. The insulin secretory response to intravenous glucagon, glucose, and the sulfonylurea tolbutamide was assessed in patients who had mutations in the gene. Six novel, heterozygous missense mutations were identified in 10 of the 29 patients. In two patients the diabetes was familial, and in eight it arose from a spontaneous mutation. Their neonatal diabetes was characterized by ketoacidosis or marked hyperglycemia and was treated with insulin. Patients did not secrete insulin in response to glucose or glucagon but did secrete insulin in response to tolbutamide. Four of the patients also had severe developmental delay and muscle weakness; three of them also had epilepsy and mild dysmorphic features. When the most common mutation in Kir6.2 was coexpressed with sulfonylurea receptor 1 in Xenopus laevis oocytes, the ability of ATP to block mutant K(ATP) channels was greatly reduced. Heterozygous activating mutations in the gene encoding Kir6.2 cause permanent neonatal diabetes and may also be associated with developmental delay, muscle weakness, and epilepsy. Identification of the genetic cause of permanent neonatal diabetes may facilitate the treatment of this disease with sulfonylureas. Copyright 2004 Massachusetts Medical Society
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Williams-Beuren syndrome.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome.

              Mitochondrial dysfunction contributes to numerous health problems, including neurological and muscular degeneration, cardiomyopathies, cancer, diabetes, and pathologies of aging. Severe mitochondrial defects can result in childhood disorders such as Leigh syndrome, for which there are no effective therapies. We found that rapamycin, a specific inhibitor of the mechanistic target of rapamycin (mTOR) signaling pathway, robustly enhances survival and attenuates disease progression in a mouse model of Leigh syndrome. Administration of rapamycin to these mice, which are deficient in the mitochondrial respiratory chain subunit Ndufs4 [NADH dehydrogenase (ubiquinone) Fe-S protein 4], delays onset of neurological symptoms, reduces neuroinflammation, and prevents brain lesions. Although the precise mechanism of rescue remains to be determined, rapamycin induces a metabolic shift toward amino acid catabolism and away from glycolysis, alleviating the buildup of glycolytic intermediates. This therapeutic strategy may prove relevant for a broad range of mitochondrial diseases.
                Bookmark

                Author and article information

                Contributors
                aristea.galanopoulou@einstein.yu.edu
                Journal
                Epilepsia Open
                Epilepsia Open
                10.1002/(ISSN)2470-9239
                EPI4
                Epilepsia Open
                John Wiley and Sons Inc. (Hoboken )
                2470-9239
                14 March 2018
                June 2018
                : 3
                : 2 ( doiID: 10.1002/epi4.2018.3.issue-2 )
                : 134-166
                Affiliations
                [ 1 ] Laboratory of Developmental Epilepsy Saul R. Korey Department of Neurology Montefiore/Einstein Epilepsy Center Albert Einstein College of Medicine Bronx New York U.S.A.
                [ 2 ] Dominick P. Purpura Department of Neuroscience Montefiore/Einstein Epilepsy Center Albert Einstein College of Medicine Bronx New York U.S.A.
                [ 3 ] Department of Pediatrics Montefiore/Einstein Epilepsy Center Albert Einstein College of Medicine Bronx New York U.S.A.
                Author notes
                [*] [* ]Address correspondence to Aristea S. Galanopoulou, 1410 Pelham Parkway South, Kennedy Center Rm 306, Bronx NY 10461, U.S.A. E‐mail: aristea.galanopoulou@ 123456einstein.yu.edu
                Article
                EPI412102
                10.1002/epi4.12102
                5983207
                58893499-c745-4209-91f5-d321c03ad6bf
                © 2018 The Authors. Epilepsia Open published by Wiley Periodicals Inc. on behalf of International League Against Epilepsy.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

                History
                : 15 January 2018
                Page count
                Figures: 0, Tables: 3, Pages: 33, Words: 25184
                Funding
                Funded by: NIH
                Award ID: U54 NS100064
                Award ID: NS43209
                Funded by: US Department of Defense
                Award ID: W81XWH‐13‐1‐0180
                Funded by: CURE Infantile Spasms Initiative
                Funded by: Heffer Family and the Segal Family Foundations
                Funded by: Abbe Goldstein/Joshua Lurie and Laurie Marsh/Dan Levitz families
                Funded by: NINDS
                Award ID: RO1 NS091170
                Award ID: U54 NS100064
                Categories
                Critical Review and Invited Commentary
                Critical Review and Invited Commentary
                Custom metadata
                2.0
                epi412102
                June 2018
                Converter:WILEY_ML3GV2_TO_NLMPMC version:version=5.4.0 mode:remove_FC converted:01.06.2018

                metabolic disorder,early onset epileptic encephalopathy,infantile spasms,inborn errors of metabolism,hypsarrhythmia

                Comments

                Comment on this article